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Culture supernatant of sepsis-associated Escherichia coli (SEPEC) isolated from patients
with sepsis caused loss of intercellular junctions and elongation of human umbilical vein
endothelial cells (HUVEC). The cytotoxic factor was puriﬁed from culture supernatant of
SEPEC 15 (serogroup O153) by liquid chromatography process. PAGE (polyacrylamide gel
electrophoresis) showed that the puriﬁed SEPEC cytotoxic factor had a molecular mass of
∼150 kDa and consisted of at least two subunits. At the concentration of 1 CD50 (40 g/mL)
did  facilitate transcytosis through the HUVEC cells monolayer of SEPEC 15 as much as E. coli
K12 within 30 min without affecting cell viability. These results suggest that this cytotoxicTranscytosis
Transendothelial electrical
resistance
factor, named as SPF (SEPEC’s permeabilizing factor), may be an important SEPEC virulence
factor that facilitates bacterial access to the bloodstream.
©  2016 Published by Elsevier Editora Ltda. This is an open access article under the CC
BY-NC-ND license. (http://creativecommons.org/licenses/by-nc-nd/4.0/)
In this study, we observed that culture supernatantBacterial sepsis is a condition in which bacteria invade the
bloodstream and infect several organs. In these cases, the
most frequently isolated microorganism from patient’s blood
is Escherichia coli.1,2 Sepsis-associated E. coli (SEPEC) belongs to
the extra-intestinal pathogenic E. coli (ExPEC) group1,3,4 and
is phylogenetically and epidemiologically different from both
intestinal pathogenic E. coli and commensal E. coli, which
are part of human microbiota.1,2 A variety of virulence fac-
tors related to human SEPEC include secreted toxins such as
HlyA (-hemolysin), Sat (secreted autotransporter toxin) and
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creativecommons.org/licenses/by-nc-nd/4.0/)CNF-1 (cytotoxic necrotizing factor 1).2,5,6 These toxins can
change the host cell shape and/or function, thereby contribut-
ing to the biological processes stimulated by the pathogen.7
Despite its medical importance, SEPEC is a poorly studied
pathotype and it is still not known how these bacteria cross
the endothelial barrier and gain access to the bloodstream.of all SEPEC strains isolated from patients with sepsis
(HC/UNICAMP, Campinas, SP, Brazil),3 were cytotoxic to
human umbilical vein endothelial cells (HUVEC), causing loss
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f intercellular junctions, cellular elongation and death. In this
ay, we  examined whether SEPEC’s cytotoxic factor facilitates
ranscytosis of these strains in HUVEC monolayers, possibly
ndicating how SEPEC may reach the bloodstream during sep-
is.
Sepsis-associated E. coli 15, serogroup O153,3 was selected
mong other SEPEC strains because this strain induced more
ntense cytotoxic effects on HUVEC cells (Fig. 1). This strain
as grown in tryptic soy broth (TSB) for 5 h at 37 ◦C. The
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culture supernatant obtained by centrifugation was con-
centrated by a rotary evaporator (Marconi, SP, Brazil) and
dialyzed (Spectrum, USA) against deionized water. This mate-
rial was submitted to Mono-Q column chromatography (GE
Healthcare), equilibrated with 0.04 M Tris–HCl, pH 8.8, and
eluted with a linear gradient of 0–1 M NaCl in the same
buffer. The elution proﬁle was then monitored at 280 nm
and fractions (1 mL/tube) were collected at a ﬂow rate of
0.5 mL/min.
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Fig. 2 – (A) Transendothelial electrical resistance (TEER) of
HUVEC monolayers after incubation with the cytotoxic
factor for 240 min. The TEER was expressed as a percentage
of the zero control. (B) Transcytosis of SEPEC15 and E. coli
K12 C600 in the absence and in the presence of puriﬁed
cytotoxic factor. *p < 0.0001.300  b r a z j i n f e c t d 
The fractions with cytotoxic activity in HUVEC cells (Fig. 1C)
were then applied on molecular exclusion chromatography
column: Superdex 75 10/300GL column (GE Healthcare) fol-
lowed by Superose 12 10/300GL column (GE Healthcare),
equilibrated with 0.04 M Tris–HCl, pH 8.8. The chromato-
graphic fractions presenting biological effects that were
obtained from all columns used in the puriﬁcation processes
were analyzed on native and sodium-dodecyl sulphate poly-
acrylamide gel electrophoresis (SDS-PAGE). The gels were
stained with silver nitrate.8
Native PAGE of the chromatographic fractions from the
last column chromatography showed only one band, indicat-
ing that the cytotoxic factor was electrophoretically puriﬁed.
However, SDS-PAGE revealed the presence of at least two
bands with molecular masses between 70 and 100 kDa, which
suggested that the SEPEC cytotoxic factor is a heterodimeric
protein complex with a molecular mass of ∼150 kDa (Fig. 1E
and F).
The CD50 of puriﬁed SEPEC cytotoxic factor (40 g/mL) was
previously described by Puerner and Borenfreund.9 The mul-
tiplicity of infection (MOI) of 20010 was determined as follows:
The number of HUVEC cells was quantiﬁed using a Neubauer
chamber and the number of CFU (colony forming units) by
previous bacterial growth standardization by spectrophoto-
metrical readings.
To assess cell monolayer permeability and transcyto-
sis, 3-m pore Transwell inserts for 24-well microplates
(ThincertsTM, Greiner Bio-One, Austria) were used. The insert
membranes were coated with 200 L of collagen (Sigma) to
give an equivalent coating of 10 mg/cm2. After this, a suspen-
sion of 1 × 105 HUVEC in 350 L of minimal essential medium
(MEM)  was applied to the top of the collagen-covered insert.
The bottom of the insert was ﬁlled with 1.2 mL  of MEM. The
microplate with inserts was incubated at 37 ◦C in a 5% CO2
atmosphere for 48 h.
To evaluate changes in monolayer permeability, the cyto-
toxic factor (1 CD50) was applied to HUVEC monolayers
grown above the insert (ThincertsTM, Greiner Bio-One, Aus-
tria) and the microplates were incubated at 37 ◦C in a 5% CO2
atmosphere (Shel Lab CO2 Incubator, OR, USA). The perme-
ability of the monolayer was monitored by measuring the
transendothelial electrical resistance (TEER) with voltohm-
meter (Millicell – ERS EMD,  Millipore, USA) after incubation
with cytotoxin for 30, 60, 90 and 120 min. Transwell inserts
coated with collagen, but without cells, were used as zero
controls. Inserts covered with collagen and cells, but with-
out cytotoxic factor, were used as negative controls. The TEER
negative control was considered as 100% since the mono-
layer was conﬂuent and unaltered. The values recorded on
the voltohmmeter were multiplied by the surface area of the
insert (0.55 cm2) to express the TEER units in /cm2.
In the transcytosis assay, the protocol were as follows: the
cytotoxic factor (1 CD50) and/or bacteria (at a multiplicity of
infection – MOI  of 200) were applied to HUVEC monolayers as
follows: puriﬁed cytotoxic factor and septicemic E. coli (SEPEC
15); the cytotoxic factor and E. coli K12 C600; just septicemic
E. coli (SEPEC 15) and E. coli K12 C600. The microplates were
incubated at 37 ◦C in a 5% CO2 atmosphere (Shel Lab CO2
Incubator, OR, USA). After 30, 60, 90, and 120 min  of incuba-
tion, 10 L of sample was collected from the lower chamberof the insert and plated on MacConkey agar and incubated at
37 ◦C for 24 h. After that the colony forming units (CFU) were
counted.
The permeability evaluation and the transcytosis assays
were done in triplicates and the results were analyzed by the
software GraphPad Prism 5 with the one way ANOVA method
with Tukeys and Dunnetts Tests, respectively.
The TEER of HUVEC monolayers was reduced by nearly 50%
after a 30 min  incubation with the cytotoxic factor, indicating
an increase in monolayer permeability (p < 0.0001). The perme-
ability stabilized from 60 minutes onwards, with a TEER that
was 62–72% of that seen in conﬂuent monolayers not exposed
to cytotoxin (Fig. 2A). Incubation with the cytotoxic factor
enhanced the translocation of bacteria across the HUVEC
monolayer since a greater number of bacteria underwent tran-
scytosis in the presence of this factor, than in cells not exposed
to the cytotoxin (p < 0.0001).
The SEPEC cytotoxic factor causes elongation and loss of
intercellular junctions in Vero (African green monkey kid-
ney epithelial) cells (data not shown), same as observed in
HUVEC cells (Fig. 1). Guyer et al.11,12 observed that SAT (auto-
transporter toxin), a protein of 142 kDa, produced by UPEC
(uropathogenic E. coli), causes a cytotoxic effect in Vero cells.
However, the SEPEC 15 does not harbor the Sat encoding-
gene.3
Furthermore, the culture supernatant of SEPEC 15 obtained
before 4 h or after 6 h of culture showed negligible or no cyto-
toxicity in HUVEC cells (data not shown). Based on the growth
pattern observed for this strain, we  suggest that the cyto-
toxic factor may be secreted mainly at the exponential growth
phase and undergoes degradation in the stationary phase,
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s observed for some proteins produced by Chlamydomonas
einhardtii.13
The measurement of the transendothelial electrical resis-
ance (TEER) showed that the SEPEC cytotoxic factor, which
aused elongation and loss of intercellular junctions in
UVEC, also increased the cell monolayer permeability by
46% within 30 min. Sandoval et al.14 reported that HUVEC
onolayer permeability could be increased by altering the
unction of the intercellular junction proteins VE-cadherins
hrough the activation of PKC (a protein kinase C isoform).
imilarly, Sukuruman and Prasadarao15 observed increased
ermeability of human brain microvascular endothelial cell
HBMEC) monolayers following the activation of PKC, but
ith a loss of functional intercellular junction proteins. The
ctivation of PKC in HBMEC involves the interaction of OmpA
outer membrane protein A) produced by E. coli K1 with the
cgp (endothelial cell glycoprotein) receptor. This interac-
ion does not occur in systemic endothelial cells such as
UVEC. Thus, we suggest that the permeability observed in
UVEC monolayers resulted from the interaction between the
ecreted cytotoxin and HUVEC-speciﬁc receptors, which then
ctivate the mechanism described by Sandoval et al.,14 and
ukuruman and Prasadarao.15 Nevertheless, further studies
re needed to conﬁrm this hypothesis.
In addition to increasing the HUVEC monolayer perme-
bility, the puriﬁed SEPEC cytotoxic factor facilitated the
ranslocation of bacteria across the monolayer (transcytosis).
his transcytosis occurred within 30 min  after infection, with-
ut affecting the viability of the monolayer. Approximately 1 h
fter infection, when >95% of the HUVEC were still viable,
pproximately 0.05% (∼1 × 104 CFU) of the bacteria applied
ere recovered in the lower chamber of the insert.
For the transcytosis assay, bacterial suspensions
MOI = 200) of SEPEC 15 or E. coli K12 C600, were applied
o the Transwell insert (ThincertsTM, Greiner Bio-One, Aus-
ria) in the addition of 1 CD50 of puriﬁed SEPEC cytotoxic
actor. The transcytosis was observed at 30 min  of infec-
ion. However, when the cytotoxin was not added, bacterial
ranslocation was observed after 1 h of infection. This effect
as probably due to the cytotoxicity of the protein on HUVEC
ells. At all post-infection intervals, a greater number of SEPEC
5 passed through the HUVEC monolayer when compared
ith the non-pathogenic strain. This observation could be
xplained by the ability of SEPEC 15 to produce and secrete
his cytotoxic factor, unlike K-12 C600. In both cases, at its
D50 concentration, the puriﬁed cytotoxin enhanced translo-
ation, resulting in a more  than two-fold increase in the
umber of bacteria crossing the monolayer without the aid of
he cytotoxin.
Thomas et al.16 showed that the Treponema pallidum,
hich causes syphilis, increased the permeability of HUVEC
onolayers and translocated through the monolayer. These
uthors16 observed that within six hours of infection, 7.2%
f the bacteria passed through the monolayer, even with a
ell viability >99%. By using electron microscopy, they showed
hat during transcytosis T. pallidum was located between the
ells and not within them, suggesting that bacterial translo-
ation involved a paracellular pathway. In contrast, Comstock
nd Thomas17 demonstrated that the translocation of Borre-
ia burgdorferi through HUVEC monolayers occurred without6;2 0(3):298–302 301
alterations in the monolayer permeability. These authors17
found that four hours after infection, 9.6% of the bacteria
had translocated and 98% of the cells were still viable. The
bacteria were observed within the cells, indicating that the
translocation of B. burgdorferi involved an intracellular path-
way. Based on these results16,17 and since, in the present study,
the translocation of E. coli was accompanied by an increase
in monolayer permeability (seen as a decrease in the TEER),
we suggest that the cytotoxic factor secreted by SEPEC 15
facilitates its passage through the endothelial barrier by a
paracellular pathway following alterations in the functional
intactness of the intercellular junctions.
Based on the results of Guyer et al.11, Kaper et al.18 sug-
gested that the Sat cytotoxin may damage venous capillaries,
which are often only one cell thick. Thus, the SEPEC cyto-
toxic factor, described here, could facilitate the passage of
bacteria through the endothelial barrier in the early stages of
sepsis in a similar way to Sat cytotoxin. However, no studies
have yet shown that Sat or any other cytotoxin secreted by
E. coli can change the permeability of endothelial cell mono-
layers and/or facilitate bacterial transcytosis. Nevertheless,
the transcytosis of E. coli and a change in endothelial cell
monolayer permeability was described by Sukuruman and
Prasadarao in 2003.15 These authors showed that E. coli K1
strain RS 218 (serotype O18:K1:H7), which is associated with
neonatal meningitis, crosses HBMEC (human brain microvas-
cular endothelial cells) monolayers with the help of the
outer membrane protein OmpA. Other studies have reported
changes in the TEER and the translocation of bacteria through
endothelial cell monolayers using different interaction bacte-
ria/endothelial cell models.10,19–21 However, the present study
is the ﬁrst to report changes in permeability in HUVEC mono-
layers caused by a cytotoxin secreted by SEPEC. Due to the
biological activity observed, we  named that cytotoxic factor
as SEPEC Permeabilizing Factor (SPF). Furthermore, our data
suggest that SPF takes part in early stages of sepsis, by assist-
ing bacterial translocation across the endothelial barrier and
facilitating access to the bloodstream. However, further stud-
ies are needed to establish the mechanisms involved in the
translocation of human SEPEC.
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